These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6891929)

  • 1. Contribution of prednisolone to the primary endocrine treatment of advanced breast cancer.
    Stewart JF; Rubens RD; King RJ; Minton MJ; Steiner R; Tong D; Winter PJ; Knight RK; Hayward JL
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1307-14. PubMed ID: 6891929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
    Rubens RD; Tinson CL; Coleman RE; Knight RK; Tong D; Winter PJ; North WR
    Br J Cancer; 1988 Nov; 58(5):626-30. PubMed ID: 3219274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer.
    Wang DY; Rubens RD; Clark GM; Moore JW; Bulbrook RD
    Breast Cancer Res Treat; 1988 Apr; 11(1):67-70. PubMed ID: 3382764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
    Blackburn AM; Wang DY; Bulbrook RD; Thomas BS; Kwa HG; Hoare SA; Rubens RD
    Cancer Treat Rep; 1984 Dec; 68(12):1447-53. PubMed ID: 6239689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential hormonal therapy for metastatic breast cancer after adjuvant tamoxifen or anastrozole.
    Carlson RW; Henderson IC
    Breast Cancer Res Treat; 2003; 80 Suppl 1():S19-26; discussion S27-8. PubMed ID: 14535531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792).
    Rubens RD; Bartelink H; Engelsman E; Hayward JL; Rotmensz N; Sylvester R; van der Schueren E; Papadiamantis J; Vassilaros SD; Wildiers J
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):667-78. PubMed ID: 2653846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen.
    Mouridsen HT; Rose C; Engelsman E; Sylvester R; Rotmensz N
    Eur J Cancer Clin Oncol; 1985 Mar; 21(3):291-9. PubMed ID: 3891357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.
    Ribeiro G; Palmer MK
    Br Med J (Clin Res Ed); 1983 Mar; 286(6368):827-30. PubMed ID: 6403101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. The Anglo-Egyptian Health Agreement Collaborative Study.
    Richards MA; Coleman RE; Hamsa R; Khaled H; el Mawla MG; Kadry I; Hablas A; Ramadan M; Allen D; Wang DY
    Eur J Surg Oncol; 1992 Jun; 18(3):219-23. PubMed ID: 1607031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
    Tripathy D; Im SA; Colleoni M; Franke F; Bardia A; Harbeck N; Hurvitz SA; Chow L; Sohn J; Lee KS; Campos-Gomez S; Villanueva Vazquez R; Jung KH; Babu KG; Wheatley-Price P; De Laurentiis M; Im YH; Kuemmel S; El-Saghir N; Liu MC; Carlson G; Hughes G; Diaz-Padilla I; Germa C; Hirawat S; Lu YS
    Lancet Oncol; 2018 Jul; 19(7):904-915. PubMed ID: 29804902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
    Gnant M; Mlineritsch B; Stoeger H; Luschin-Ebengreuth G; Heck D; Menzel C; Jakesz R; Seifert M; Hubalek M; Pristauz G; Bauernhofer T; Eidtmann H; Eiermann W; Steger G; Kwasny W; Dubsky P; Hochreiner G; Forsthuber EP; Fesl C; Greil R;
    Lancet Oncol; 2011 Jul; 12(7):631-41. PubMed ID: 21641868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
    Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
    Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
    Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
    Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Christie hospital adjuvant tamoxifen trial--status at 10 years.
    Ribeiro G; Swindell R
    Br J Cancer; 1988 Jun; 57(6):601-3. PubMed ID: 3044432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
    Fentiman IS; Howell A; Hamed H; Lee SM; Ranson M; Wall J; Chaudary MA; Ash CM; Gregory WM; Sellwood RA
    Br J Cancer; 1994 Oct; 70(4):729-31. PubMed ID: 7917929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer. A prospective randomized study.
    Cocconi G; De Lisi V; Boni C; Mori P; Malacarne P; Amadori D; Giovanelli E
    Cancer; 1983 Feb; 51(4):581-8. PubMed ID: 6336981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
    Gnant M; Mlineritsch B; Schippinger W; Luschin-Ebengreuth G; Pöstlberger S; Menzel C; Jakesz R; Seifert M; Hubalek M; Bjelic-Radisic V; Samonigg H; Tausch C; Eidtmann H; Steger G; Kwasny W; Dubsky P; Fridrik M; Fitzal F; Stierer M; Rücklinger E; Greil R; ; Marth C
    N Engl J Med; 2009 Feb; 360(7):679-91. PubMed ID: 19213681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.